Sandoz launches authorized Adderall XR generic

PRINCETON, N.J. — Sandoz on Thursday announced the launch of its authorized generic of Shire’s Adderall XR (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate) extended-release capsules. The drug is indicated to treat attention deficit/hyperactivity disorder in children. 

 

Sandoz’s authorized generic will be manufactured and supplied by Shire in 5-, 10-, 15-, 20-, 25- and 30-mg dosage strengths. The drug had U.S. sales of about $1.9 billion for the 12 months ended June 2016, according to IMS Health data.